RAM
XENE icon

Readystate Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History

Readystate Asset Management’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,814
Closed -$777K – 727
2025
Q2 		$777K Buy
+24,814
New +$809K 0.02% 225

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Readystate Asset Management's XENE Position: Q3 2025 in Review

Readystate Asset Management sold out of Xenon Pharmaceuticals (XENE) in Q3 2025, closing a stake of 24,814 shares — an estimated $777K sold.

Readystate Asset Management first reported a position in XENE in Q2 2025 and held it in 1 quarter. The position peaked at $777K in Q2 2025. 219 funds tracked by Wall St. Rank hold XENE as of Q3 2025.

  • Readystate Asset Management reported no remaining Xenon Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Readystate Asset Management sold 24,814 Xenon Pharmaceuticals shares in Q3 2025, an estimated $777K.
  • Readystate Asset Management first reported a position in Xenon Pharmaceuticals in Q2 2025 and held it in 1 quarter.
  • Readystate Asset Management's Xenon Pharmaceuticals position peaked at $777K in Q2 2025.
  • 219 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2025.

Based on Readystate Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.